These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
655 related articles for article (PubMed ID: 5147595)
21. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
22. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related]
23. US drug shortages are set to reach record high in 2011, report says. Tanne JH BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406 [No Abstract] [Full Text] [Related]
24. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community]. Battaglino G Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380 [No Abstract] [Full Text] [Related]
25. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
26. 2013 State Compounding Legislation Tracker. Miller DG Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782 [No Abstract] [Full Text] [Related]
27. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
28. End-preparation assessments and tests for compounded sterile preparations. McElhiney LF Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146 [TBL] [Abstract][Full Text] [Related]
29. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913 [TBL] [Abstract][Full Text] [Related]
30. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474 [TBL] [Abstract][Full Text] [Related]
31. Protecting consumers from counterfeit drugs. FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838 [No Abstract] [Full Text] [Related]
32. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
33. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061 [TBL] [Abstract][Full Text] [Related]
34. Essential elements of quality control. Boylan JC Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523 [TBL] [Abstract][Full Text] [Related]
35. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
36. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
37. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [TBL] [Abstract][Full Text] [Related]
38. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
39. Quality planning, part 1: a holistic and practical approach. Odegard RD Int J Pharm Compd; 2013; 17(5):393-9. PubMed ID: 24459786 [TBL] [Abstract][Full Text] [Related]